Researchers have developed a technique that allows them to revive parts of human hearts in the laboratory for up to 12 hours while they search for hidden sources of irregular heartbeats.
As the useful applications of big data in the pharmaceutical and healthcare sector become increasingly apparent, 73 percent of organizations in the industry are set to begin or increase investment in big data within the next five years, according to business intelligence provider GBI Research.
How healthy is your cath lab supply chain? Do you struggle with managing inventory across your cath lab supply chain? It ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Baylor Heart and Vascular Services at Fort Worth in November became the first program in Texas to implant the Amplatzer PFO Occluder. The device is designed to help reduce the risk of recurrent cryptogenic strokes in patients diagnosed with a patent foramen ovale (PFO) – a small opening between the upper chambers of the heart.
This video, provided by Medtronic, demonstrates the CardioInsight electro-anatomical mapping system. It was cleared by ...
February 1, 2017 — Medtronic received U.S. Food and Drug Administration (FDA) 510(k) clearance for the CardioInsight ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
A new national survey by Orlando Health found that most women are unaware of the age at which heart screenings should begin. The American Heart Association recommends women begin undergoing regular heart screenings at age 20, but the survey found the majority of women, 60 percent, thought screenings didn't need to begin until after age 30, at least a full decade later.
Heart Test Laboratories Inc. (HTL) has successfully raised $12 million by way of a Common Stock private placement offering. The offering was significantly over-subscribed and provides HTL with a strong financial base entering into 2017. The company expects to commence the international launch of its MyoVista product in the first quarter.
To save the life of an 11-year-old boy, Ann & Robert H. Lurie Children’s Hospital of Chicago has become the first pediatric hospital in the United States to implant the 50cc SynCardia temporary Total Artificial Heart.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Cigna and HeartWell LLP have launched a program to improve quality and cost of care for people diagnosed with chronic coronary artery disease.
W. L. Gore & Associates (Gore) announced that the Gore Viabahn VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) has received U.S. Food & Drug Administration (FDA) approval for treatment of de novo or restenotic lesions found in iliac arteries. The approval includes lesions at the aortic bifurcation. This marks the availability of the only balloon expandable stent graft with an indication for the iliac artery.
January 31, 2017 — The American College of Cardiology (ACC) issued a statement against President Donald Trump’s recent ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
January 31, 2017 — Bard Peripheral Vascular Inc. is recalling the Halo One Thin-Walled Guiding Sheath because the sheath ...
Annual waste for high-value medical devices continues to grow at a rapid pace. With bundled payments putting increased ...
Computerized and semi-automated inventory control system technology offers a more efficient way for cardiovascular departments, especially catheterization and electrophysiology (EP) labs, to track what is on their shelves. These systems can help re-order supplies, track the department’s actual costs per procedure and identify new ways to cut costs.